It is well known that the Covid vaccine, co – developed by Astrogenene and Oxford Universities in India, is being used in the form of Kovshield in the context of Corona. The vaccine is also being exported from India to other countries. It was during this time that the World Health Organization (WHO) approved the emergency use of two Kovid vaccines from AstraZeneca. This will make the Covid vaccine available to the poorest countries in the world.
Gas Subsidy: Just a simple message to the gas agency, your subsidy will not stop
Through the Kovacs program, the World Health Organization, in collaboration with donors and NGOs, has launched a program to provide the Covid vaccine to poor countries. It is in this context that two estrogenic vaccines have been approved and the vaccines will be delivered to poorer countries by Kovacs. This allows them to get the vaccine in a timely manner.
In the past, it has been said that the Kovshield vaccine used in India is effective against corona at 92 per cent. For that, two doses have to be taken. It is a vaccine variant of Astrogenica, Oxford. The second variant is being produced by Astrogeneneka-SK Bio. It has been revealed that the variant affects 63% of the population. The World Health Organization has already approved the emergency use of the Pfizer-Bioentech Kovid vaccine in the United States.
